DE69614393D1 - Herpes simplex viren diagnostik - Google Patents

Herpes simplex viren diagnostik

Info

Publication number
DE69614393D1
DE69614393D1 DE69614393T DE69614393T DE69614393D1 DE 69614393 D1 DE69614393 D1 DE 69614393D1 DE 69614393 T DE69614393 T DE 69614393T DE 69614393 T DE69614393 T DE 69614393T DE 69614393 D1 DE69614393 D1 DE 69614393D1
Authority
DE
Germany
Prior art keywords
herpes simplex
simplex virus
hsv
methods
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614393T
Other languages
English (en)
Other versions
DE69614393T2 (de
Inventor
Lyn Burke
D Anna Alexander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE69614393D1 publication Critical patent/DE69614393D1/de
Publication of DE69614393T2 publication Critical patent/DE69614393T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69614393T 1995-07-28 1996-06-20 Herpes simplex viren diagnostik Expired - Fee Related DE69614393T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50859895A 1995-07-28 1995-07-28
US08/613,235 US5965354A (en) 1995-07-28 1996-03-08 Herpes simplex virus diagnostics
PCT/US1996/010615 WO1997005488A1 (en) 1995-07-28 1996-06-20 Herpes simplex virus diagnostics

Publications (2)

Publication Number Publication Date
DE69614393D1 true DE69614393D1 (de) 2001-09-20
DE69614393T2 DE69614393T2 (de) 2001-11-22

Family

ID=27056239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614393T Expired - Fee Related DE69614393T2 (de) 1995-07-28 1996-06-20 Herpes simplex viren diagnostik

Country Status (11)

Country Link
US (1) US5965354A (de)
EP (1) EP0842430B1 (de)
JP (1) JPH11510893A (de)
AT (1) ATE204083T1 (de)
AU (1) AU6284996A (de)
CA (1) CA2227844A1 (de)
DE (1) DE69614393T2 (de)
ES (1) ES2159032T3 (de)
GR (1) GR3037090T3 (de)
PT (1) PT842430E (de)
WO (1) WO1997005488A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384640B1 (en) * 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
WO2002033418A1 (en) * 2000-10-17 2002-04-25 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
KR100898648B1 (ko) * 2001-06-07 2009-05-22 와이어쓰 홀딩스 코포레이션 보조제로서 콜레라 홀로톡신의 돌연변이체 형태
CA2449670A1 (en) * 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
AU2003290775A1 (en) * 2002-11-14 2004-06-03 Ciphergen Biosystems, Inc. Biomarkers for intra-amniotic inflammation
AU2004235349B2 (en) * 2003-04-25 2009-11-19 Becton, Dickinson And Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
US7763460B2 (en) * 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
DE112008000888T5 (de) 2007-04-04 2011-05-19 Hugh Birchwood McTavish Nichtspezifische verzögerte Überempfindlichkeitsreaktion zur Behandlung von Herpes-Simplex-Virusinfektionen
ES2711177T3 (es) 2013-12-18 2019-04-30 Board Of Trustees Southern Illinois Univ Un ensayo serológico rápido y sensible para determinar si los pacientes están infectados por el virus del herpes simple de tipo 1 (VHS-1) y/o de tipo 2 (VHS-2)
CN107427540A (zh) 2015-02-26 2017-12-01 斯垮瑞斯有限责任公司 用于治疗单纯疱疹病毒感染的非特异性延迟型过敏反应
WO2017134061A1 (en) * 2016-02-01 2017-08-10 Gu Ventures Ab Truncated glycoprotein g of herpes simplex virus 2
CN112584862A (zh) * 2018-05-17 2021-03-30 伊米若梅有限公司 Ch3结构域表位标签

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US4764459A (en) * 1984-12-28 1988-08-16 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-linked immunosorbent assay (ELISA) for determining anti-bodies against herpes simplex virus (HSV) types 1 and 2 in human sera
EP0471778A1 (de) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Proteine und polypeptide des glykoproteins g vom herpes simplex-virus
CA2081888A1 (en) * 1990-05-04 1991-11-05 Mark Norman Bobrow Method of determining type specific antibodies to herpes simplex virus types 1 and 2
EP0541692B1 (de) * 1990-08-02 1999-05-06 Chiron Corporation Herpes simplex virus vp16 impfstoffe

Also Published As

Publication number Publication date
ES2159032T3 (es) 2001-09-16
ATE204083T1 (de) 2001-08-15
EP0842430B1 (de) 2001-08-08
DE69614393T2 (de) 2001-11-22
PT842430E (pt) 2001-11-30
AU6284996A (en) 1997-02-26
WO1997005488A1 (en) 1997-02-13
GR3037090T3 (en) 2002-01-31
US5965354A (en) 1999-10-12
JPH11510893A (ja) 1999-09-21
CA2227844A1 (en) 1997-02-13
EP0842430A1 (de) 1998-05-20

Similar Documents

Publication Publication Date Title
Grangeot-Keros et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women
ATE204083T1 (de) Herpes simplex viren diagnostik
Ashley Laboratory techniques in the diagnosis of herpes simplex infection.
CA2075183A1 (en) Specimen test slide and method of testing for fecal occult blood
Schmid et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2
NZ306051A (en) Testing using electrochemiluminescence
Ascher et al. Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting
DE3485653D1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zell-leukozytenantikoerpern.
WO1999009410A3 (en) Rapid assay for simultaneous detection and differentiation of antibodies to hiv
WO2004048600A3 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
Genser et al. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard
DE69819643T2 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
DK0946874T3 (da) Diagnose af Helicobacter Pylori
Dalessio et al. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot
SE8900721D0 (sv) Methods for detection of antibodies to
Safrin et al. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS
CN108469520B (zh) 一种干式免疫层析检测仪及其检测方法
Ashley et al. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection
CN216900577U (zh) 一种用于多病原体的IgM和IgG共检测的免疫层析试剂盒
CA2276491A1 (en) Early detection of mycobacterial disease
CA2174212A1 (en) Assay to detect hcv receptor binding
KR20150004491U (ko) 비인두암 진단 방법 및 진단 장치
Shekarchi et al. Comparison of enzyme-linked immunosorbent assay with enzyme-linked fluorescence assay with automated readers for detection of rubella virus antibody and herpes simplex virus
Kiefer et al. Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee